Company research / CYAN

Cyanotech Corp (CYAN)

SEC name CYANOTECH CORP · CIK 0000768408 · OTC · Medicinal Chemicals & Botanical Products

  • Sector Manufacturing
  • Incorporated NV
  • Fiscal year ends Mar 31

Not updated since 2025-03-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

For the year ended 2025-03-31, Cyanotech Corp reported revenue of $24.21M. Revenue grew 5.0% from the prior annual period. Over the twelve months to 2025-09-30, revenue was $25.27M.

Key ratios (year ended 2025-03-31)

28.4%
Gross margin
-10.4%
Operating margin
-13.2%
Net margin
-36.1%
Return on year-end equity
5.0%
Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 10-Q (quarterly report) · 2025-11-10

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2025-09-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2025-09-30
2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-31
Revenue$25.27M$24.21M$23.07M$23.18M$35.97M$32.34M$31.90M$30.20M$34.12M$32.04M$31.84M
Cost of Revenue$17.18M$17.34M$17.13M$15.92M$22.40M$21.23M$19.20M$19.74M$20.74M$19.82M$19.97M
Gross Profit$8.09M$6.88M$5.95M$7.26M$13.57M$11.12M$12.70M$10.47M$13.37M$12.22M$11.87M
R&D Expense$380.0K$449.0K$689.0K$770.0K$712.0K$639.0K$608.0K$923.0K$563.0K$593.0K$633.0K
Operating Income-$1.06M-$2.51M-$4.59M-$2.92M$2.57M$84.0K$1.05M-$3.00M$1.41M-$682.0K-$785.0K
Depreciation & Amortization$1.44M$1.48M$1.59M$1.66M$1.60M$1.75M$1.93M$1.91M$1.88M$1.98M$1.52M
EBITDA$380.0K-$1.03M-$3.00M-$1.26M$4.17M$1.83M$2.99M-$1.09M$3.29M$1.30M$735.0K
Net Income-$1.78M-$3.20M-$5.27M-$3.44M$2.15M$920.0K$387.0K-$3.60M$1.02M-$1.22M-$4.39M
EPS (Diluted)n/an/a-$0.81-$0.55$0.35$0.15$0.06-$0.62$0.18-$0.21-$0.79
Total Assets$24.03M$23.49M$25.11M$29.73M$32.05M$30.88M$31.79M$29.63M$29.71M$29.16M$31.15M
Total Liabilities$15.96M$14.61M$13.30M$13.38M$12.56M$13.84M$15.94M$14.72M$11.60M$12.55M$13.32M
Long-Term Debt$4.22M$4.71M$5.46M$4.46M$4.94M$6.17M$6.87M$126.0K$156.0Kn/an/a
Shareholders' Equity$8.06M$8.88M$11.81M$16.35M$19.49M$17.04M$15.85M$14.91M$18.11M$16.61M$17.83M
Cash & Equivalents$649.0K$257.0K$707.0K$974.0K$2.59M$3.77M$2.42M$840.0K$1.33M$1.41M$1.24M
Operating Cash Flow-$1.21M-$1.19M-$455.0K-$2.10M$2.38M$2.40M$1.24M-$847.0K$1.49M$1.22M$745.0K
Capital Expendituresn/an/an/an/an/an/an/a$431.0K$1.00M$847.0K$4.30M
Free Cash Flown/an/an/an/an/an/an/a-$1.28M$485.0K$373.0K-$3.56M
Shares Outstanding7.39M7.20M6.95M6.27M6.20M6.12M6.01M5.88M5.77M5.69M5.60M
Weighted Average Diluted Sharesn/an/an/a6.24M6.17M6.08M5.96M5.82M5.78M5.66M5.58M
EPS (Basic)n/a-$0.45-$0.81-$0.55$0.35$0.15$0.06-$0.62$0.18-$0.21-$0.79